National Institute on Aging; Notice of Closed Meeting, 73792 [2021-28091]
Download as PDF
<![CDATA[
73792
Federal Register / Vol. 86, No. 246 / Tuesday, December 28, 2021 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Conference Rooms C, D&E, and
F&G, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Director Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757 malikk@
niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.niddk.nih.gov/fund/divisions/DEA/
Council/coundesc.htm., where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: December 21, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Age-related
metabolites, mitochondrial and synaptic
degeneration & rescue in Aging and
Alzheimer’s disease.
Date: March 23, 2022.
Time: 11:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Anita H. Undale, MD,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building, Suite 2W200, 7201 Wisconsin
Avenue, Bethesda, MD 20892, 301–827–
7428, anita.undale@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 21, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–28091 Filed 12–27–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive Patent
License: ‘‘Griffithsin Compositions for
Treatment and Prevention of Anti-Viral
Infections’’
AGENCY:
National Institutes of Health,
HHS.
Notice.
[FR Doc. 2021–28097 Filed 12–27–21; 8:45 am]
ACTION:
BILLING CODE 4140–01–P
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Sep<11>2014
22:45 Dec 27, 2021
Jkt 256001
The National Cancer Institute
(NCI), National Institutes of Health,
Department of Health and Human
Services, is contemplating the grant of
an exclusive, sublicensable patent
license to University of Louisville
Research Foundation, (‘‘ULRF’’) in its
rights to the inventions and patents
listed in the Supplementary Information
section of this notice. ULRF is a
Kentucky 501(c)3 non-profit corporation
that is the agent of the University of
Louisville (‘‘UofL’’) for licensing
intellectual property owned and
controlled by ULRF on behalf of UofL.
DATES: Only written comments and/or
applications for a license which are
received by the NCI Technology
Transfer Center January 12, 2022 will be
considered.
ADDRESSES: Requests for copies of the
patent applications, inquiries, and
comments relating to the contemplated
exclusive patent license should be
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
directed to: Taryn Dick, Ph.D., MBA,
Licensing and Patenting Manager at
Telephone: (301) 631–3007 or Email:
taryn.dick@nih.gov.
SUPPLEMENTARY INFORMATION: The
following and all continuing U.S. and
foreign patents/patent applications
thereof are the intellectual properties to
be licensed under the prospective
agreement to ULRF: U.S. Provisional
Patent Application No. 63/026,375
entitled ‘‘Compositions and Methods for
Prevention of Coronavirus Infection,’’
(HHS Ref. No. E–029–2022–0–US–01),
filed 18 May 2020; PCT Application No.
PCT/US2021/033009 entitled
‘‘Compositions and Methods for
Prevention of Coronavirus Infection,’’
(HHS Ref. No. E–029–2022–1–PCT–02),
filed May 18, 2021; U.S. Provisional
Patent Application No. 62/898,383
entitled ‘‘Anti-Viral Compositions and
Methods of Making and Using,’’ (HHS
Ref. No. E–030–2022–0–US–01), filed
September 10, 2019; and PCT
Application No. PCT/US2020/050200,
entitled ‘‘Anti-Viral Compositions and
Methods of Making and Using’’ (HHS
Ref. No. E–030–2022–0–PCT–02), filed
September 10, 2020.
PCT/US2021/033009 described above
claims priority to the U.S. Provisional
Patent Application No. 63/026,375
described above, as well as a second
U.S. Provisional Patent Application No.
63/070,375 entitled ‘‘Q–Griffithsin
Nasal Spray,’’ (HHS Ref. No. E–029–
2022–1–US–01), filed on August 26,
2020. The Government of the United
States is not a co-owner on this second
U.S. Provisional Patent Application, and
it is therefore, excluded from the
proposed exclusive grant from NCI to
ULRF.
With respect to the inventions
described and claimed in the patent
applications 62/026,375 (E–029–2022–
0–US–01) and PCT/US2021/033009 (E029–2022–1–PCT–02) each of the
inventors has assigned their rights to
their respective employers or an entity
which manages the intellectual property
for their employer (The Government of
the United States of America, the
University of Louisville Research
Foundation, Inc. or the University of
Pittsburgh). With respect to the
inventions described and claimed in the
patent applications 62/898,383 (E–030–
2022–0–US–01) and PCT/US2021/
050200 (E–030–2022–0–PCT–01) each
of the inventors has assigned their rights
to their respective employers or an
entity which manages the intellectual
property for their employer (The
Government of the United States or the
University of Louisville Research
Foundation, Inc.). The prospective
E:\FR\FM\28DEN1.SGM
28DEN1
]]>Agencies
[Federal Register Volume 86, Number 246 (Tuesday, December 28, 2021)]
[Notices]
[Page 73792]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28091]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Age-related metabolites, mitochondrial and synaptic
degeneration & rescue in Aging and Alzheimer's disease.
Date: March 23, 2022.
Time: 11:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892 (Video Meeting).
Contact Person: Anita H. Undale, MD, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute on Aging,
National Institutes of Health, Gateway Building, Suite 2W200, 7201
Wisconsin Avenue, Bethesda, MD 20892, 301-827-7428,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: December 21, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-28091 Filed 12-27-21; 8:45 am]
BILLING CODE 4140-01-P
